Issue navigation
Volume 4, Issue 3, September 2022
Articles
POLQ suppresses genome instability and alterations in DNA repeat tract lengths
NAR Cancer, Volume 4, Issue 3, September 2022, zcac020, https://doi.org/10.1093/narcan/zcac020
Unmasking the mammalian SET domain-containing protein 4
NAR Cancer, Volume 4, Issue 3, September 2022, zcac021, https://doi.org/10.1093/narcan/zcac021
DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model
NAR Cancer, Volume 4, Issue 3, September 2022, zcac022, https://doi.org/10.1093/narcan/zcac022
KMT2C-deficient tumors have elevated APOBEC mutagenesis and genomic instability in multiple cancers
NAR Cancer, Volume 4, Issue 3, September 2022, zcac023, https://doi.org/10.1093/narcan/zcac023
KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)
NAR Cancer, Volume 4, Issue 3, September 2022, zcac024, https://doi.org/10.1093/narcan/zcac024
Differential RNA aptamer affinity profiling on plasma as a potential diagnostic tool for bladder cancer
NAR Cancer, Volume 4, Issue 3, September 2022, zcac025, https://doi.org/10.1093/narcan/zcac025
PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer
NAR Cancer, Volume 4, Issue 3, September 2022, zcac026, https://doi.org/10.1093/narcan/zcac026
SFPQ promotes RAS-mutant cancer cell growth by modulating 5′-UTR mediated translational control of CK1α
NAR Cancer, Volume 4, Issue 3, September 2022, zcac027, https://doi.org/10.1093/narcan/zcac027
